586 related articles for article (PubMed ID: 18035075)
1. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
Li F; Zhang G; Zhao W
Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic activity in coronary heart disease.
Yao SK; Chen ZJ; Tao SQ
Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
Habib SS; Abdel Gader AG; Kurdi MI; Suriya MO; Al Aseri Z
J Pak Med Assoc; 2012 Jul; 62(7):681-5. PubMed ID: 23866515
[TBL] [Abstract][Full Text] [Related]
6. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
7. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
8. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
Pedersen OD; Gram J; Jespersen J
Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
[TBL] [Abstract][Full Text] [Related]
11. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
13. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
[TBL] [Abstract][Full Text] [Related]
14. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
15. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
Orbe J; Zudaire M; Serrano R; Coma-Canella I; Martínez de Sizarrondo S; Rodríguez JA; Páramo JA
Thromb Haemost; 2008 Feb; 99(2):382-7. PubMed ID: 18278189
[TBL] [Abstract][Full Text] [Related]
16. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
Hlatky MA; Ashley E; Quertermous T; Boothroyd DB; Ridker P; Southwick A; Myers RM; Iribarren C; Fortmann SP; Go AS;
Am Heart J; 2007 Dec; 154(6):1043-51. PubMed ID: 18035073
[TBL] [Abstract][Full Text] [Related]
20. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
